| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr17:45949400-45953200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
| 2 |
chr17:45950000-45954600 |
Weak transcription |
Lung |
lung
|
| 3 |
chr17:45950400-45953600 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
| 4 |
chr17:45950400-45955400 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
| 5 |
chr17:45950600-45954000 |
Enhancers |
Placenta |
Placenta
|
| 6 |
chr17:45950600-45955600 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
| 7 |
chr17:45950800-45955200 |
Weak transcription |
HSMM |
muscle
|
| 8 |
chr17:45951000-45953000 |
Enhancers |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
| 9 |
chr17:45951000-45953400 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
| 10 |
chr17:45951000-45955400 |
Weak transcription |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
| 11 |
chr17:45951200-45952600 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 12 |
chr17:45951200-45953400 |
Enhancers |
Fetal Thymus |
thymus
|
| 13 |
chr17:45951600-45953400 |
Bivalent Enhancer |
iPS-15b Cell Line |
embryonic stem cell
|
| 14 |
chr17:45951600-45953600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 15 |
chr17:45951800-45952800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
| 16 |
chr17:45951800-45953000 |
Bivalent Enhancer |
ES-WA7 Cell Line |
embryonic stem cell
|
| 17 |
chr17:45951800-45953200 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
| 18 |
chr17:45951800-45953200 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
| 19 |
chr17:45951800-45953600 |
Bivalent Enhancer |
ES-I3 Cell Line |
embryonic stem cell
|
| 20 |
chr17:45952000-45952600 |
Enhancers |
Fetal Lung |
lung
|
| 21 |
chr17:45952000-45952800 |
Weak transcription |
K562 |
blood
|
| 22 |
chr17:45952000-45953000 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
| 23 |
chr17:45952000-45953000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 24 |
chr17:45952000-45953200 |
Enhancers |
HSMMtube |
muscle
|
| 25 |
chr17:45952000-45953400 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 26 |
chr17:45952000-45953400 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
| 27 |
chr17:45952000-45953400 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 28 |
chr17:45952200-45953000 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 29 |
chr17:45952200-45953000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
| 30 |
chr17:45952200-45953200 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
| 31 |
chr17:45952200-45953200 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
| 32 |
chr17:45952200-45953200 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 33 |
chr17:45952200-45953400 |
Bivalent Enhancer |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
| 34 |
chr17:45952200-45953400 |
Enhancers |
Fetal Intestine Large |
intestine
|
| 35 |
chr17:45952400-45952600 |
Bivalent Enhancer |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
| 36 |
chr17:45952400-45952600 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
| 37 |
chr17:45952400-45952800 |
Bivalent Enhancer |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
| 38 |
chr17:45952400-45953000 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
| 39 |
chr17:45952400-45953000 |
Enhancers |
HMEC |
breast
|
| 40 |
chr17:45952400-45953200 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
| 41 |
chr17:45952400-45953200 |
Enhancers |
Osteobl |
bone
|
| 42 |
chr17:45952400-45953800 |
Enhancers |
Adipose Nuclei |
Adipose
|
